Skip to main content
Erschienen in: Orphanet Journal of Rare Diseases 1/2022

Open Access 01.12.2022 | Research

Poor education and urgent information need for emergency physicians about rare diseases in China

verfasst von: Lingli Zhou, Jun Xu, Jing Yang

Erschienen in: Orphanet Journal of Rare Diseases | Ausgabe 1/2022

Abstract

Background

Rare diseases are serious and chronic diseases that affect no more than 1 person in 2000 (in European Union criteria). Patients suffering from RDs may come to the emergency department for life-threatening symptoms, such as acute aortic dissection, intracranial haemorrhage, and severe respiratory distress. Diagnostic delay of rare disease patients is common and often caused by low rare disease awareness among physicians. The main aim of this study was to investigate Chinese emergency physicians’ basic knowledge, information access and educational needs regarding rare diseases. An online questionnaire was completed by Chinese emergency physicians during January and March 2021.

Methods and results

A total of 539 emergency physicians, including 200 females and 339 males, responded to the questionnaire-based study. More than half of the respondents were from Tertiary A hospitals and had engaged in medical clinical work for more than 10 years. Only 4.27% of respondents correctly estimated the prevalence of rare diseases. A few respondents knew the exact number of RDs in the first official list of rare diseases in 2018. A total of 98.5% of respondents rated their knowledge about rare diseases as minimal or insufficient. Most emergency physicians preferred to obtain information through search engines instead of specialized websites on rare diseases. A lack of practice guidelines or consensus was considered the most important reason for the diagnostic delay of RD. Practice guidelines or consensus and professional websites on rare diseases are urgently needed for emergency physicians.

Conclusion

The investigation shows poor knowledge of rare diseases among emergency physicians. Practice guidelines and professional websites on rare diseases were the primary urgent needs for emergency physicians. Specialized RD courses should also be added to medical education.
Hinweise
Lingli Zhou and Jun Xu contributed equally to this work

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Rare diseases (RDs) are diseases affect no more than 1 person in 2000, according to the European Union, and they are always serious, chronic, and often life-threatening conditions [1]. It has been estimated that 6–8% of the population will be affected by a rare disease [2], which means that there are at least 16.8 million RD patients in China. RDs are characterized by a severe condition, difficult diagnosis, high misdiagnosis rate and low curable rate, and the main patients are teenagers. Due to the high clinical complexity, patients with RDs often face lengthy diagnostic delays, with some families seeing between 3 and 10 different doctors and waiting > 5 years for a definitive diagnosis [3, 4].
Patients living with RDs face tremendous social and economic difficulties [5]. RDs need to be taken seriously and approached urgently. In recent years, China, like many other countries, is doing all it can to improve the health and wellbeing of patients with rare diseases. The National Rare Disease Registry System in China (https://​www.​nrdrs.​org.​cn) and the Rare Diseases Clinical Cohort Study were established in 2016 [6]. The National Health Commission declared the first list of rare diseases, including 121 rare diseases in 2018 and established the National Network of Rare Diseases (NNRD, https://​www.​nrdrs.​org.​cn) in 2019 for the diagnosis and treatment of rare diseases. The rare disease map has been designed for the management of RDs. Meanwhile, progress has been made in the limited availability of orphan drugs in China [7].
A wide range of health professionals were involved in diagnosing rare diseases, such as general practitioners, pediatricians, geneticists, and neurologists [3, 8]. General practitioners play an important role in the diagnosis and managements of rare disease patients [9, 10]. In China, general practice in its infancy and public health care is poor. Emergency physicians take on some of the responsibilities of general practitioners. Patients with rare diseases often seek medical assistance in emergency room(ER). Such as acute porphyria, patients usually come to emergency department for abdominal pain and constipation, with most of the patients diagnosed as having an intestinal obstruction and even accepted an enterectomy [11]. Patients with acquired hemophilia A present with repeated bleeding, delayed diagnosis and treatment endanger their lives [12]. The acute severity of RDs makes the clinical work of emergency physicians more challenging. Therefore, the knowledge of emergency physicians on RDs is important.
Previous studies have shown that health care professionals and medical students lack training and experience on RDs [2, 13]. Chinese health professionals are trying to train medical professionals to recognize rare disorders and make improvements in diagnosis and treatment [7]. The Guide for the Diagnosis and Treatment of RDs in Chinese was published in 2019 [14]. The first textbook in Chinese on rare diseases was published in Oct 2020 [15]. Recent research showed that only 5.3% of Chinese physicians were moderately aware or well aware of RDs [16]. The current situation of Chinese emergency physicians’ knowledge about rare diseases has not been reported. Our study aims to describe Chinese emergency physicians’ clinical practice regarding RDs, their information-seeking behaviours and their educational needs and preferences.

Materials and methods

The study was conducted between January and March 2021 among emergency physicians in China. A separate online data-collection questionnaire was used for the survey through a web platform (www.​wjx.​cn), which permits centralized data collection and limits repetition by mobile numbers. The survey was conducted with a standard questionnaire that was constructed from themes based on a review of the literature and the study aim. It included 30 questions: 6 questions that addressed their demographic data and 24 items referring to respondents' knowledge of and attitudes towards RDs. The questionnaire consisted of four groups of questions. The first group included six questions referring to demographic information, including gender, career length, hospital level, technical titles, licensing province and whether the respondents had any advanced training experience in other hospitals.
The second group of thirteen questions concentrated on the emergency physicians’ knowledge of RDs. The respondents were asked about the incidence (in European Union criteria) and number of RDs. Progress has been made in policies defining RDs and limiting the availability of orphan drugs in China. Three questions referred to the current situation of RDs in China, including the estimated number of RD patients, whether there was any national registry system and the exact number of RDs in the first list of RDs in 2018. Four items were related to orphan drugs, the hereditary nature, and the most common age of onset of RDs. Baseline data and updated information on the prevalence of RDs in China are unavailable [17]. We listed 27 RDs that were relatively common in the clinic according to an analysis of hospitalization reports for RDs in China [18] and the experience of our emergency department. Therefore, all respondents were asked to indicate which RD they had encountered from that list of 27 RDs. The respondents were asked if they had first diagnosed any RD. The 140 respondents who had first diagnosed an RD were asked the number of RDs they had seen in their career and to indicate which RDs they first diagnosed from a list of twenty RDs; they could also indicate any RDs that they first diagnosed that were not on the list.
The third group included six questions related to the respondents' self-assessment and information access on RDs. The respondents were asked how they perceived their knowledge about RDs, whether they had any classes on RDs, how they learned about them, and which access route was the most effective. Two questions referred to which website they preferred for learning about RD and which professional websites on RDs they had used.
The last group of five questions referred to emergency physicians’ needs for RD information. The respondents were asked if they would like to learn more about RDs and the reasons delaying the diagnosis of RDs. The authors also wanted to know which aspect of RDs the emergency physicians preferred to learn more about. Finally, the respondents were asked which specialty requires more in-depth training on RDs and whether it is necessary to add an RD course to their medical school education. Ethics approval and research governance approval were obtained from Peking Union Medical College Hospital.
Statistical testing was performed using SPSS Statistics 25.0. The respondents were divided into different groups according to career length, hospital, and title. The rate of correct answers was the percent of respondents choosing the right answer in each group. The rate of correct results was analysed with the chi-squared test to reveal significant differences (p < 0.05).

Results

Demography

A total of 539 emergency physicians answered the questionnaire. All respondents were from China, including 27 of 34 Chinese provincial administrative regions, with the top five in Hubei (83, 15.4%), Liaoning (70, 12.99%), Guangxi (65, 12.06%), Henan (41, 7.61%), and Jiangxi (38, 7.05%). The demographic information of these respondents is listed in Table 1. Of 539 emergency physicians, 200 (37.11%) were female and 339 (62.89%) were male, while 244 (45.27%) had engaged in medical clinical work for more than 15 years. In China, a 3-tier system was established to recognize a hospital’s comprehensive abilities in medical care, education, and research [16]. Of 539 emergency physicians, 337 (62.52%) were from Tertiary A (the highest level) hospitals, while 65 (12.06%) were from Tertiary B hospitals and 137 (25.42%) were from secondary hospitals. The responders in this study included 99 (18.37%) residents, 209 (38.78%) attendings, 170 (31.54%) associate chief physicians and 61 (11.32%) chief physicians. A total of 331 (61.41%) respondents had advanced training experience in other hospitals.
Table 1
Demographic information of emergency physicians
Characteristic
Respondents (n = 539)
n
%
Gender
  
 Female
200
37.11%
 Male
339
62.89%
Career length (years)
  
 < 5
64
11.87%
 5 ~ 10
86
15.96%
 10 ~ 15
145
26.90%
 > 15
244
45.27%
Hospital
  
 Tertiary A
337
62.52%
 Tertiary B
65
12.06%
 Secondary
137
25.42%
Title
  
 Resident
99
18.37%
 Attending
209
38.78%
 Associate chief physician
170
31.54%
 Chief physician
61
11.32%
Advanced training experience
  
 No
208
38.59%
 Yes
331
61.41%

Knowledge

Respondents’ knowledge about RDs is shown in Table 2. Only 23 (4.27%) respondents correctly estimated the prevalence of RD (in European Union criteria), and 115 (21.34%) knew the number of RDs. Forty-four (8.16%) respondents were aware of the number of patients suffering from RD in China, while 199 (36.92%) knew that there was a national registry system for RDs in China. Ninety-three (17.25%) respondents knew the exact number of RDs in the first list of RDs in 2018, and 105 (19.48%) were aware of the percentage of RDs with orphan drugs. A total of 509 (94.43%) respondents knew that not all RDs were hereditary, but only 97 (18%) knew the percentage of hereditary diseases in RDs. A total of 147 (27.27%) respondents knew the most common age of onset of RDs. Only 140 (25.97%) respondents had first diagnosed an RD. Out of the 140 respondents, 98 (70%) had seen less than ten types of RD, 32 (22.86%) had seen ten to twenty types and only 10 (7.14%) had seen more than twenty types. For six core questions on RD, the rate of correct responses of respondents from different groups is shown in Fig. 1. The result of the chi-squared test shows that from different career length, hospital and title groups, the respondents have a similar knowledge rate of RD (p > 0.05). Only in the correctness of responses to “Is there any national register system for RD in China” did the respondents from secondary hospitals have a lower rate than those from Tertiary A or B hospitals (p < 0.05), and the rate of correct answers was not significantly different between Tertiary A and Tertiary B hospitals (p > 0.05).
Table 2
Emergency physicians’ knowledge of rare diseases
Items
n
%
Incidence of RD (in European Union criteria)
 
 < 1: 1000
66
12.24%
 < 1: 2000 [19]
23
4.27%
 < 1: 10,000
259
48.05%
 I do not know
191
35.44%
Number of RDs in the world
  
 600–800
93
17.25%
 6000–8000 [19]
115
21.34%
 60,000–80,000
18
3.34%
 I do not know
313
58.07%
Number of patients suffering from RD in China
 200,000
101
18.74%
 2,000,000
112
20.78%
 20,000,000 [7]
44
8.16%
 200,000,000
0
0%
 I do not know
282
52.32%
Is there any national register system for RD in China?
 Yes [7]
199
36.92%
 No
28
5.19%
 I do not know
312
57.88%
The exact number of RDs in the first list of rare diseases in 2018
 121 [17]
93
17.25%
 147
95
17.63%
 I do not know
351
65.12%
The percent of RDs with orphan drugs
 
 0%
11
2.04%
 5% [5]
105
19.48%
 10%
41
7.61%
 20%
23
4.27%
 50%
6
1.11%
 I do not know
353
65.49%
Are all RDs hereditary?
  
 Yes
30
5.57%
 No [13]
509
94.43%
The percentage of hereditary diseases among RDs
 
 20%
100
18.55%
 50%
72
13.36%
 80% [13]
97
18%
 100%
2
0.37%
 I do not know
268
49.72%
The most common age of onset of RD
 
 Neonatal period
45
8.35%
 Childhood [30]
147
27.27%
 Adulthood
37
6.86%
 Equal in all age groups
143
26.53%
 I do not know
167
30.98%
Have you first diagnosed an RD in a patient?
  
 Yes
140
25.97%
 No
399
74.03%
How many RDs have you seen in your career? *
 
 1 ~ 5
54
38.57%
 5 ~ 10
44
31.43%
 10 ~ 15
22
15.71%
 15 ~ 20
10
7.14%
 > 20
10
7.14%
Correct answers are indicated in bold and bolditalics
*This question was given to 140 respondents who first diagnosed an RD
The respondents were presented a list of twenty-seven RDs and asked to select those they had seen or first diagnosed (Table 3). For the 539 responding emergency physicians, the most common RDs they had seen were Marfan syndrome (49.17%), haemophilia (46.75%), idiopathic pulmonary fibrosis (46.01%), multiple sclerosis (41.37%) and idiopathic pulmonary arterial hypertension (40.63%). For the 140 emergency physicians who had first diagnosed RD, the most frequent RDs they first diagnosed were Marfan syndrome (38.57%), generalized myasthenia gravis (34.29%), idiopathic pulmonary arterial hypertension (30%), idiopathic pulmonary fibrosis (29.29%) and multiple sclerosis (24.29%).
Table 3
Which of the following rare diseases have been seen or first diagnosed?
Rare diseases
Which of the following rare diseases have you seen? (n = 539)
Which of the following rare diseases have you first diagnosed? (n = 140)
Idiopathic pulmonary arterial hypertension
219
40.63%
42
30%
Idiopathic pulmonary fibrosis
248
46.01%
41
29.29%
IgG4-related disease
79
14.66%
16
11.43%
Lymphangioleiomyomatosis
45
8.35%
4
2.86%
Marfan syndrome
265
49.17%
54
38.57%
Multiple sclerosis
223
41.37%
34
24.29%
POMES syndrome
76
14.10%
12
8.57%
Porphyria
143
26.53%
24
17.14%
Albinism
204
37.85%
27
19.29%
Atypical haemolytic uraemic syndrome
49
9.09%
9
6.43%
Autoimmune encephalitis
157
29.13%
30
21.43%
Castleman disease
42
7.79%
3
2.14%
Congenital scoliosis
125
23.19%
19
13.57%
Diamond-Blackfan anaemia
38
7.05%
3
2.14%
Fanconi anaemia
35
6.49%
3
2.14%
Gaucher disease
42
7.79%
3
2.14%
Generalized myasthenia gravis
218
40.45%
48
34.29%
Glycogen storage disease
51
9.46%
2
1.43%
Haemophilia
252
46.75%
30
21.43%
Hepatolenticular degeneration
157
29.13%
32
22.86%
Pulmonary alveolar proteinosis
71
13.17%
16
11.43%
Amyotrophic lateral sclerosis
115
21.34%
Congenital myasthenic syndrome
63
11.69%
Huntington disease
59
10.95%
Idiopathic cardiomyopathy
61
11.32%
Langerhans cell histiocytosis
74
13.73%
Systemic sclerosis
173
32.10%
Others
10
1.86%
13
9.29%
The top five are indicated in bold

Self-assessment and information access

The responses on self-assessment and information access on RDs are listed in Table 4. Only 1 (0.19%) respondent thought that he or she knew RDs well and 7 (1.30%) respondents considered themselves as having moderate knowledge, while 158 (29.31%) had insufficient knowledge and 373 (69.20%) had minimal knowledge of RDs. Most respondents (74.95%) did not take a course on rare diseases in their medical education. A total of 376 (69.76%) respondents learned about RDs in clinical work, and 232 (43.04%) thought it was the most effective way. A total of 412 (76.44%) respondents preferred Baidu for more information about RDs, and only 20 (3.71%) learned from professional websites on rare diseases. A total of 255 (47.31%) respondents had used the National Rare Disease Registry System of China. The answers to “How did you learn about RDs?” and “Which websites do you prefer to learn more about RD?” are shown in Fig. 2, and they were distinguished by different career lengths and hospital groups. With longer career length, the proportion of respondents learning about RDs by studying in medical school was lower. The respondents with longer career lengths had a lower preference for learning about RDs through PubMed. The respondents from secondary hospitals presented a lower proportion of having studied RDs in medical school or through academic websites, such as PubMed, CNKI, VIP and WanFang, but a high proportion of learning about RDs by advanced training in other hospitals and attending academic conferences.
Table 4
Self-assessment and information access of rare diseases
Items
N
%
How well do you know about rare diseases?
 Well
1
0.19%
 Somewhat
7
1.30%
 Insufficiently
158
29.31%
 Minimally
373
69.20%
Was there any rare disease course in your medical education?
 Yes
84
15.58%
 No
404
74.95%
 I do not know
51
9.46%
How did you learn about rare diseases?
 
 Studying in medical school
248
46.01%
 Browsing RD websites
118
21.89%
 Working in clinic
376
69.76%
 Advanced training in other hospitals
216
40.07%
 Attending academic conferences
342
63.45%
 Others
40
7.42%
 Never heard of them
20
3.71%
Which access was most effective for you?
 
 Studying in medical school
29
5.38%
 Surfing RD website
38
7.05%
 Working in clinic
232
43.04%
 Advanced training in other hospital
103
19.11%
 Attending academic conferences
124
23.01%
 Others
13
2.41%
Which websites do you prefer to use to learn more about RDs?
 PubMed
128
23.75%
 Baidu
412
76.44%
 Wikipedia
79
14.66%
 Uptodate
103
19.11%
 Rare disease specialist website
20
3.71%
 DXY
329
61.04%
 CNKI or VIP or WangFang
114
21.15%
 I do not want to know about them
7
1.30%
 Others
22
4.08%
Which professional websites on RD have you used?
 
 OMIM
71
13.17%
 National Rare Disease Registry System of China
255
47.31%
 Orphanet Portal for rare diseases
35
6.49%
 ERAM or PEDAM
62
11.50%
 Others
222
41.19%

Information needs

Emergency physicians’ needs for RD information are shown in Table 5. Almost all respondents (92.21%) wanted to learn more about RD. A total of 450 (83.49%) respondents thought that a lack of practice guidelines or consensus delayed the diagnosis of rare disease. In addition, 466 (86.46%) preferred to learn more information about RDs by diagnostic guidelines or consensus. The distribution of information needs with the answer to “Which aspect of RDs do you prefer to learn more about?” is displayed by different career length and hospital groups (Fig. 3). Each group of career length or hospital had a similar proportion of information need. The respondents with more than 15 years of career experience or from secondary hospitals had a high proportion of needing relevant professional websites and hospitals or specialists that they could refer to. Half of the respondents (51.21%) thought that every physician, regardless of specialization, needed in-depth training on RDs. Moreover, 254 (47.12%) respondents thought that emergency physicians need more training on RDs, and 475 (88.13%) declared that it was necessary to add courses on rare diseases in medical school education.
Table 5
Emergency physicians’ needs for RD information
Items
N
%
Would you like to know more about rare diseases?
 Yes
497
92.21%
 No
4
0.74%
 I'm not sure
38
7.05%
The reasons delaying the diagnosis of rare disease
 Lack of practice guidelines or consensus
450
83.49%
 Do not know how to find relevant professional websites
271
50.28%
 Do not know a hospital or specialist that I can refer to
252
46.75%
 Lack of material or official account to disseminate to patients or their family
225
41.74%
 Do not know a hospital or specialist for genetic counselling
277
51.39%
Which aspect of rare diseases do you prefer to learn more about?
 Practice guidelines or consensus
466
86.46%
 Relevant professional websites
370
68.65%
 A hospital or specialist that I can refer to
308
57.14%
 Material or official account to disseminate to patients or their family
267
49.54%
 A hospital or specialist for genetic counselling
271
50.28%
Which specialty needs more in-depth training on rare diseases?
 Paediatrician
156
28.94%
 General practitioner
212
39.33%
 Neurologist
110
20.41%
 Geneticist
186
34.51%
 Physician
139
25.79%
 Emergency physician
254
47.12%
 Every physician regardless of specialization
276
51.21%
 Other
9
1.67%
 None
4
0.74%
Is it necessary to add a course on rare disease to your medical school education?
 Yes
475
88.13%
 No
32
5.94%
 Depends on the course content
32
5.94%

Discussion

The most common definitions for what constitute a rare disease are the eligibility criteria used by drug regulatory agencies. Thus, different regions have different definitions. In the European Union, a disease is rare when it affects fewer than 1 in 2,000 people, whereas a rare disease is defined as a condition that affects fewer than 200,000 people in the United States [19]. In China, the first list of rare diseases was published in 2018, although there is no official definition for RDs. The incidence of each rare disease is not clear. The rare disease thematic maps are developing for management and in-depth research on RDs [20]. The questionnaire results indicated that emergency physicians have poor knowledge of RD and that an urgent need for RD information does exist. Although most respondents had been in medical practice for more than five years and half of them had advanced training experience, they lacked basic knowledge about RDs. Only 4.27% of respondents knew that a disease with an incidence lower than 1 in 2000 is defined as an RD in European Union criteria [19]. More than half of the respondents had no idea about the epidemiology, registry system or the first official list of RDs in China. Only eighteen percent of emergency physicians knew that 80% of RDs are hereditary, while 27.27% knew that the onset of RDs most frequently appears in childhood. The underestimation of the profile of rare diseases might indicate a low level of rare disease awareness.
Of our subjects, 98.5% rated their knowledge about RDs as minimal or insufficient, while Walkowiak et al. [21] reported that 94.6% of physicians in Poland perceived their knowledge of RDs as insufficient or very poor. Chinese physicians showed a similar result in a self-assessment on RDs: only 5.3% (12/224) had moderate or good awareness of RDs [16]. These results may be related to the low prevalence, complicated condition, and difficult diagnosis of RDs, which usually require multidisciplinary consultation.
To the best of our knowledge, this is the first research concentrated on emergency physicians’ education and information about RDs in China. A similarly poor cognitive level about RDs has also been reported in physicians [16, 22], surgeons [23], medical students [13], nurses and nursing students [24]. Meanwhile, from our research, only a quarter of respondents had experience with the first diagnosis of RDs (140, 25.97%). Although RDs are chronic diseases and are mostly diagnosed by specialists, patients suffering from RDs may come to the emergency department for life-threatening symptoms before the first diagnosis of RD. Our survey finds, the most frequent RDs first diagnosed by ER doctors were Marfan syndrome (38.57%), generalized myasthenia gravis (34.29%), idiopathic pulmonary arterial hypertension (30%), idiopathic pulmonary fibrosis (29.29%) and multiple sclerosis (24.29%). Since Marfan syndrome always not be diagnosed until an individual presents with an acute aortic dissection [25]. For haemophilia, intracranial haemorrhage can be a potentially deadly complication [26, 27]. Patients can present with severe respiratory distress when suffering from idiopathic pulmonary fibrosis, multiple sclerosis, idiopathic pulmonary arterial hypertension, or generalized myasthenia gravis [28, 29]. The above data also shows that in China, if emergency physicians lack knowledge on RDs, many RD patients with acute symptoms may miss their first chance for diagnosis.
Diagnostic delay is one of the most common problems encountered while caring for RD patients [30]. A survey of 462 Australian children living with RDs showed that 38% consulted ≥ 6 different doctors before receiving the correct diagnosis, 37% believed the diagnosis was delayed, and 27% initially received a wrong diagnosis [3]. Yan et al. [31] investigated the diagnosis experience of 1,010 adult RD patients in China. The results indicated that 72.97% of patients were misdiagnosed; they waited an average of 4.3 years and visited 2.97 hospitals before receiving the definitive diagnosis of an RD [31]. Many countries include UK highlighted the integral role of general practice, computer learning and diagnostic algorithms can aid Rds diagnosis and minimise clinician error [32].Although China has made great progress in the field of health care in the past decade, family medical services are still relatively inadequate, and emergency physicians deal with all patients in emergency cases and are responsible for further treatment and referrals, emergency physicians usually need to act as general practitioners. Therefore, it is important to improve the awareness of RDs among Chinese ER doctors, which can reduce the misdiagnosis of RDs and shorten the diagnosis delay time.
The routes to enhance the knowledge of RDs include medical school, clinical work, academic conferences and online. In our study, clinical work and academic conferences were thought to be the most common and effective forms of access for learning about rare diseases. We found that the respondents from secondary hospitals presented a lower proportion of having studied RDs in medical school or through academic websites but a high proportion of learning RDs by advanced training in other hospitals and attending academic conferences. The reason may be that secondary hospitals are closer to community hospitals, and there are fewer opportunities to acquire knowledge of RDs from daily work. Most emergency physicians also preferred to learn about RDs at academic conferences, where specialists would share vivid cases of RDs. As learning from clinical work and academic conferences are not systemic and has great uncertainty, through the years, technologies like functional imaging have changed our way of seeing and interpreting the RDs[33],enhance the ability of our emergency physicians to self-learn is very important.
Pauer et al. [34] indicated that the quality of information on the internet about RDs is low. The information about RDs from most popular websites our subjects prefer, such as Baidu (a common search engine in China, http://​www.​baidu.​com/​) and DXY (a platform for professional medical communication in China, http://​www.​dxy.​cn/​), are not professional. Only 3.71% of respondents preferred professional websites for learning more about RDs, and less than half had used the National Rare Disease Registry System of China (https://​www.​nrdrs.​org.​cn/​). The National Network of RDs could increase the communication of physicians from different hospitals and improve the diagnosis and treatment of RDs [14, 35]. A complete professional RD website is conducive to diagnosis and in-depth study on RD in the clinical work of emergency physicians and can also serve as a sharing platform of academic conferences. Therefore, popularizing and simplifying the professional websites on rare diseases should be made a top priority.
In 2019, the first Chinese Guide for the Diagnosis and Treatment of RDs was published [14]. But our emergency physicians still regarded the lack of practice guidelines or consensus as the most important reason for the diagnostic delay of RD. For most of emergency physicians, this guide needs more popularization and interpretation, especially in awareness of critical conditions of RDs. A total of 47.12% of respondents considered that emergency physicians needed more in-depth training on RD, and 92.21% were willing to learn more. Only 15.58% of emergency physicians had taken RD courses in their medical education, a survey in medical students showed similarly poor education on RDs [13]. In undergraduate or postgraduate medical education, less than one-third of the physicians had received training in rare diseases in Spain [2]. Vandeborne et al. reported that most physicians had specific information needs regarding RDs in Belgium and that attending continuous training sessions on RDs could improve knowledge and awareness of RDs [22]. Academic and continuous medical education should focus on “red flags” to increase RD attentiveness and provide easy access to educational opportunities and information resources regarding RD [2, 22]. The first Chinese textbook on RDs was published in 2020 to fill the gap in the medical education of clinical students [15]. E-learning programs and courses for RDs should also be organized [21].We plan to develop RD training courses for urgent and critical conditions of RDs based on the results of this survey. As the internet is the most convenient access of information, publishing online practice guidelines and popularizing professional websites on RDs are also urgent needs that could be effective for emergency physicians.

Limitations

This is a questionnaire-based study on emergency physicians. Some items might be inaccurate, as they were answered on account of the respondents’ memory, and objective medical records were not used. The demographic distribution of respondents may be different from that of all emergency physicians. The emergency physicians who responded to this questionnaire may be more concerned with RD than those who refused to participate. Thus, this study was limited by underlying inaccurate responses to questionnaires and possible selection bias.

Conclusion

In conclusion, the investigation shows poor knowledge and urgent information needs regarding RD in emergency physicians. It is imperative for the public health system to improve the training on RDs of emergency physicians, including by adding specialized RD courses in medical education, providing practice guidelines, and popularizing professional websites on RDs.

Acknowledgements

We are very grateful to every ER doctor who completed this questionnaire for their support.

Declarations

All procedures followed were in accordance with the ethical standards of the responsible institutional committee on human experimentation and with the Helsinki Declaration of 1975 (revised in 2000). The study protocol was approved by the ethics committee of the institutional review board at Peking Union Medical College Hospital (PUMCH). A questionnaire and a list of open-ended questions for interviews were designed in Chinese. Potential participants were invited to participate in this study, and only those who signed the informed consent online could participate in this study.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Richter T, Nestler-Parr S, Babela R, Khan ZM, Tesoro T, Molsen E, Hughes DA. International Society for p, outcomes research rare disease special interest G: rare disease terminology and definitions-a systematic global review: report of the ISPOR rare disease special interest group. Value Health. 2015;18(6):906–14.CrossRef Richter T, Nestler-Parr S, Babela R, Khan ZM, Tesoro T, Molsen E, Hughes DA. International Society for p, outcomes research rare disease special interest G: rare disease terminology and definitions-a systematic global review: report of the ISPOR rare disease special interest group. Value Health. 2015;18(6):906–14.CrossRef
2.
Zurück zum Zitat Ramalle-Gomara E, Dominguez-Garrido E, Gomez-Eguilaz M, Marzo-Sola ME, Ramon-Trapero JL, Gil-de-Gomez J. Education and information needs for physicians about rare diseases in Spain. Orphanet J Rare Dis. 2020;15(1):18.CrossRef Ramalle-Gomara E, Dominguez-Garrido E, Gomez-Eguilaz M, Marzo-Sola ME, Ramon-Trapero JL, Gil-de-Gomez J. Education and information needs for physicians about rare diseases in Spain. Orphanet J Rare Dis. 2020;15(1):18.CrossRef
3.
Zurück zum Zitat Zurynski Y, Deverell M, Dalkeith T, Johnson S, Christodoulou J, Leonard H, Elliott EJ. group ARDIoFS: Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet J Rare Dis. 2017;12(1):68.CrossRef Zurynski Y, Deverell M, Dalkeith T, Johnson S, Christodoulou J, Leonard H, Elliott EJ. group ARDIoFS: Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet J Rare Dis. 2017;12(1):68.CrossRef
4.
Zurück zum Zitat Avellaneda Fernandez A, Layola M, Izquierdo Martinez M, Guilera M, BadiaLlach X, Ramon JR. Sociosanitary impact on patients with rare diseases (ERES study). Med Clin (Barc). 2007;129(17):646–51.CrossRef Avellaneda Fernandez A, Layola M, Izquierdo Martinez M, Guilera M, BadiaLlach X, Ramon JR. Sociosanitary impact on patients with rare diseases (ERES study). Med Clin (Barc). 2007;129(17):646–51.CrossRef
5.
Zurück zum Zitat Dong D, Wang Y. Challenges of rare diseases in China. Lancet. 2016;387(10031):1906.CrossRef Dong D, Wang Y. Challenges of rare diseases in China. Lancet. 2016;387(10031):1906.CrossRef
6.
Zurück zum Zitat Feng S, Liu S, Zhu C, Gong M, Zhu Y, Zhang S. National rare diseases registry system of china and related cohort studies: vision and roadmap. Hum Gene Ther. 2018;29(2):128–35.CrossRef Feng S, Liu S, Zhu C, Gong M, Zhu Y, Zhang S. National rare diseases registry system of china and related cohort studies: vision and roadmap. Hum Gene Ther. 2018;29(2):128–35.CrossRef
7.
Zurück zum Zitat Zhang S, Chen L, Zhang Z, Zhao Y. Orphan drug development in China: progress and challenges. Lancet. 2019;394(10204):1127–8.CrossRef Zhang S, Chen L, Zhang Z, Zhao Y. Orphan drug development in China: progress and challenges. Lancet. 2019;394(10204):1127–8.CrossRef
8.
Zurück zum Zitat Anderson M, Elliott EJ, Zurynski YA. Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis. 2013;8:22.CrossRef Anderson M, Elliott EJ, Zurynski YA. Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis. 2013;8:22.CrossRef
9.
Zurück zum Zitat Knight AW, Senior TP. The common problem of rare disease in general practice. Med J Aust. 2006;185(2):82–3.CrossRef Knight AW, Senior TP. The common problem of rare disease in general practice. Med J Aust. 2006;185(2):82–3.CrossRef
10.
Zurück zum Zitat Boffin N, Swinnen E, Wens J, Urbina M, Van der Heyden J, Van Casteren V. General practice care for patients with rare diseases in Belgium. A cross-sectional survey. Int J Environ Res Public Health 2018;15(6). Boffin N, Swinnen E, Wens J, Urbina M, Van der Heyden J, Van Casteren V. General practice care for patients with rare diseases in Belgium. A cross-sectional survey. Int J Environ Res Public Health 2018;15(6).
11.
Zurück zum Zitat Yang J, Chen Q, Yang H, Hua B, Zhu T, Zhao Y, Zhu H, Yu X, Zhang L, Zhou Z. Clinical and laboratory features of acute porphyria: a study of 36 subjects in a Chinese tertiary referral center. Biomed Res Int. 2016;2016:3927635.PubMedPubMedCentral Yang J, Chen Q, Yang H, Hua B, Zhu T, Zhao Y, Zhu H, Yu X, Zhang L, Zhou Z. Clinical and laboratory features of acute porphyria: a study of 36 subjects in a Chinese tertiary referral center. Biomed Res Int. 2016;2016:3927635.PubMedPubMedCentral
12.
Zurück zum Zitat Tiede A, Collins P, Knoebl P, Teitel J, Kessler C, Shima M, Di Minno G, d’Oiron R, Salaj P, Jiménez-Yuste V, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020;105(7):1791–801.CrossRef Tiede A, Collins P, Knoebl P, Teitel J, Kessler C, Shima M, Di Minno G, d’Oiron R, Salaj P, Jiménez-Yuste V, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020;105(7):1791–801.CrossRef
13.
Zurück zum Zitat Domaradzki J, Walkowiak D. Medical students’ knowledge and opinions about rare diseases: A case study from Poland. Intractable Rare Dis Res. 2019;8(4):252–9.CrossRef Domaradzki J, Walkowiak D. Medical students’ knowledge and opinions about rare diseases: A case study from Poland. Intractable Rare Dis Res. 2019;8(4):252–9.CrossRef
14.
Zurück zum Zitat s.y. Z: The Guide for the Diagnosis and Treatment of Rare Diseases: people’s medical publishing house 2020. s.y. Z: The Guide for the Diagnosis and Treatment of Rare Diseases: people’s medical publishing house 2020.
15.
Zurück zum Zitat Zhang s.y. Zyp: textbook on rare diseases: people’s medical publishing house; 2020. Zhang s.y. Zyp: textbook on rare diseases: people’s medical publishing house; 2020.
16.
Zurück zum Zitat Li X, Zhang X, Zhang S, Lu Z, Zhang J, Zhou J, Li B, Ou L. Rare disease awareness and perspectives of physicians in China: a questionnaire-based study. Orphanet J Rare Dis. 2021;16(1):171.CrossRef Li X, Zhang X, Zhang S, Lu Z, Zhang J, Zhou J, Li B, Ou L. Rare disease awareness and perspectives of physicians in China: a questionnaire-based study. Orphanet J Rare Dis. 2021;16(1):171.CrossRef
17.
Zurück zum Zitat He J, Tang M, Zhang X, Chen D, Kang Q, Yang Y, Hu J, Jin C, Song P. Incidence and prevalence of 121 rare diseases in China: current status and challenges. Intractable Rare Dis Res. 2019;8(2):89–97.CrossRef He J, Tang M, Zhang X, Chen D, Kang Q, Yang Y, Hu J, Jin C, Song P. Incidence and prevalence of 121 rare diseases in China: current status and challenges. Intractable Rare Dis Res. 2019;8(2):89–97.CrossRef
18.
Zurück zum Zitat Shi X, Liu H, Zhan S, Wang Z, Wang L, Dong C, Wang Y, Yao C, Ding J, Li Y. Rare diseases in China: analysis of 2014–2015 hospitalization summary reports for 281 rare diseases from 96 tertiary hospitals. Orphanet J Rare Dis. 2019;14(1):160.CrossRef Shi X, Liu H, Zhan S, Wang Z, Wang L, Dong C, Wang Y, Yao C, Ding J, Li Y. Rare diseases in China: analysis of 2014–2015 hospitalization summary reports for 281 rare diseases from 96 tertiary hospitals. Orphanet J Rare Dis. 2019;14(1):160.CrossRef
19.
Zurück zum Zitat Haendel M, Vasilevsky N, Unni D, Bologa C, Harris N, Rehm H, Hamosh A, Baynam G, Groza T, McMurry J, et al. How many rare diseases are there? Nat Rev Drug Discov. 2020;19(2):77–8.CrossRef Haendel M, Vasilevsky N, Unni D, Bologa C, Harris N, Rehm H, Hamosh A, Baynam G, Groza T, McMurry J, et al. How many rare diseases are there? Nat Rev Drug Discov. 2020;19(2):77–8.CrossRef
20.
Zurück zum Zitat Dai G, Liu X, Chen Q. Development of the rare disease map. Chinese General Practice. 2021;24(28):3643–7. Dai G, Liu X, Chen Q. Development of the rare disease map. Chinese General Practice. 2021;24(28):3643–7.
21.
Zurück zum Zitat Walkowiak D, Domaradzki J. Are rare diseases overlooked by medical education? Awareness of rare diseases among physicians in Poland: an explanatory study. Orphanet J Rare Dis. 2021;16(1):400.CrossRef Walkowiak D, Domaradzki J. Are rare diseases overlooked by medical education? Awareness of rare diseases among physicians in Poland: an explanatory study. Orphanet J Rare Dis. 2021;16(1):400.CrossRef
22.
Zurück zum Zitat Vandeborne L, van Overbeeke E, Dooms M, De Beleyr B, Huys I. Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis. 2019;14(1):99.CrossRef Vandeborne L, van Overbeeke E, Dooms M, De Beleyr B, Huys I. Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis. 2019;14(1):99.CrossRef
23.
Zurück zum Zitat Kuhne A, Kleinheinz J, Jackowski J, Koppe J, Hanisch M. Study to investigate the knowledge of rare diseases among dentists, orthodontists, periodontists, oral surgeons and craniomaxillofacial surgeons. Int J Environ Res Public Health 2020;18(1). Kuhne A, Kleinheinz J, Jackowski J, Koppe J, Hanisch M. Study to investigate the knowledge of rare diseases among dentists, orthodontists, periodontists, oral surgeons and craniomaxillofacial surgeons. Int J Environ Res Public Health 2020;18(1).
24.
Zurück zum Zitat Walkowiak D, Domaradzki J. Needs assessment study of rare diseases education for nurses and nursing students in Poland. Orphanet J Rare Dis. 2020;15(1):167.CrossRef Walkowiak D, Domaradzki J. Needs assessment study of rare diseases education for nurses and nursing students in Poland. Orphanet J Rare Dis. 2020;15(1):167.CrossRef
25.
Zurück zum Zitat Milewicz DM, Braverman AC, De Backer J, Morris SA, Boileau C, Maumenee IH, Jondeau G, Evangelista A, Pyeritz RE. European reference network for rare multisystemic vascular disease HRDWG: Marfan syndrome. Nat Rev Dis Primers. 2021;7(1):64.CrossRef Milewicz DM, Braverman AC, De Backer J, Morris SA, Boileau C, Maumenee IH, Jondeau G, Evangelista A, Pyeritz RE. European reference network for rare multisystemic vascular disease HRDWG: Marfan syndrome. Nat Rev Dis Primers. 2021;7(1):64.CrossRef
26.
Zurück zum Zitat Senapati SB, Mishra SS, Dhir MK, Das S. Intracerebellar haemorrage in a haemophilia child. Asian J Neurosurg. 2016;11(2):179.CrossRef Senapati SB, Mishra SS, Dhir MK, Das S. Intracerebellar haemorrage in a haemophilia child. Asian J Neurosurg. 2016;11(2):179.CrossRef
27.
Zurück zum Zitat Hermans C, Noone D, Benson G, Dolan G, Eichler H, Jimenez-Yuste V, Konigs C, Lobet S, Pollard D, Zupancic-Salek S et al. Hemophilia treatment in 2021: Choosing the “optimal" treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. Blood Rev. 2021:100890. Hermans C, Noone D, Benson G, Dolan G, Eichler H, Jimenez-Yuste V, Konigs C, Lobet S, Pollard D, Zupancic-Salek S et al. Hemophilia treatment in 2021: Choosing the “optimal" treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. Blood Rev. 2021:100890.
28.
Zurück zum Zitat Koch-Henriksen N, Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol. 2021;17(11):676–88.CrossRef Koch-Henriksen N, Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol. 2021;17(11):676–88.CrossRef
29.
Zurück zum Zitat Wu N, Yu YF, Chuang CC, Wang R, Benjamin NN, Coultas DB. Healthcare resource utilization among patients diagnosed with idiopathic pulmonary fibrosis in the United States. J Med Econ. 2015;18(4):249–57.CrossRef Wu N, Yu YF, Chuang CC, Wang R, Benjamin NN, Coultas DB. Healthcare resource utilization among patients diagnosed with idiopathic pulmonary fibrosis in the United States. J Med Econ. 2015;18(4):249–57.CrossRef
30.
Zurück zum Zitat Zurynski Y, Gonzalez A, Deverell M, Phu A, Leonard H, Christodoulou J, Elliott E. Rare disease: a national survey of paediatricians’ experiences and needs. BMJ Paediatr Open. 2017;1(1): e000172.CrossRef Zurynski Y, Gonzalez A, Deverell M, Phu A, Leonard H, Christodoulou J, Elliott E. Rare disease: a national survey of paediatricians’ experiences and needs. BMJ Paediatr Open. 2017;1(1): e000172.CrossRef
31.
Zurück zum Zitat Yan X, He S, Dong D. Determining how far an adult rare disease patient needs to travel for a definitive diagnosis: a cross-sectional examination of the 2018 national rare disease survey in china. Int J Environ Res Public Health 2020;17(5). Yan X, He S, Dong D. Determining how far an adult rare disease patient needs to travel for a definitive diagnosis: a cross-sectional examination of the 2018 national rare disease survey in china. Int J Environ Res Public Health 2020;17(5).
32.
Zurück zum Zitat Evans WR, Rafi I. Rare diseases in general practice: recognising the zebras among the horses. Br J Gen Pract. 2016;66(652):550–1.CrossRef Evans WR, Rafi I. Rare diseases in general practice: recognising the zebras among the horses. Br J Gen Pract. 2016;66(652):550–1.CrossRef
33.
Zurück zum Zitat Cacciaguerra G, Palermo M, Marino L, Rapisarda FAS, Pavone P, Falsaperla R, Ruggieri M, Marino S. The evolution of the role of imaging in the diagnosis of craniosynostosis: a narrative review. Children (Basel) 2021;8(9). Cacciaguerra G, Palermo M, Marino L, Rapisarda FAS, Pavone P, Falsaperla R, Ruggieri M, Marino S. The evolution of the role of imaging in the diagnosis of craniosynostosis: a narrative review. Children (Basel) 2021;8(9).
34.
Zurück zum Zitat Pauer F, Litzkendorf S, Gobel J, Storf H, Zeidler J, Grafvonder Schulenburg JM. Rare diseases on the internet: an assessment of the quality of online information. J Med Internet Res. 2017;19(1): e23.CrossRef Pauer F, Litzkendorf S, Gobel J, Storf H, Zeidler J, Grafvonder Schulenburg JM. Rare diseases on the internet: an assessment of the quality of online information. J Med Internet Res. 2017;19(1): e23.CrossRef
35.
Zurück zum Zitat Reinhard C, Bachoud-Levi AC, Baumer T, Bertini E, Brunelle A, Buizer AI, Federico A, Gasser T, Groeschel S, Hermanns S, et al. The European reference network for rare neurological diseases. Front Neurol. 2020;11: 616569.CrossRef Reinhard C, Bachoud-Levi AC, Baumer T, Bertini E, Brunelle A, Buizer AI, Federico A, Gasser T, Groeschel S, Hermanns S, et al. The European reference network for rare neurological diseases. Front Neurol. 2020;11: 616569.CrossRef
Metadaten
Titel
Poor education and urgent information need for emergency physicians about rare diseases in China
verfasst von
Lingli Zhou
Jun Xu
Jing Yang
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
Orphanet Journal of Rare Diseases / Ausgabe 1/2022
Elektronische ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-022-02354-1

Weitere Artikel der Ausgabe 1/2022

Orphanet Journal of Rare Diseases 1/2022 Zur Ausgabe